IRIS
MONFORTE, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.809
EU - Europa 7.534
AS - Asia 4.155
SA - Sud America 1.291
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 23.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.683
RU - Federazione Russa 3.852
SG - Singapore 1.608
CN - Cina 1.116
BR - Brasile 1.114
IE - Irlanda 888
SE - Svezia 732
VN - Vietnam 678
UA - Ucraina 577
DE - Germania 398
HK - Hong Kong 380
IT - Italia 265
FR - Francia 221
GB - Regno Unito 204
FI - Finlandia 197
IN - India 85
AR - Argentina 65
CA - Canada 58
MX - Messico 46
TR - Turchia 39
AT - Austria 38
BD - Bangladesh 36
EC - Ecuador 35
PL - Polonia 33
IQ - Iraq 32
ZA - Sudafrica 31
CZ - Repubblica Ceca 27
JP - Giappone 24
MA - Marocco 22
NL - Olanda 21
BE - Belgio 20
CO - Colombia 20
UZ - Uzbekistan 19
CI - Costa d'Avorio 15
ES - Italia 15
PK - Pakistan 15
ID - Indonesia 13
SA - Arabia Saudita 13
VE - Venezuela 13
IR - Iran 12
PY - Paraguay 10
BO - Bolivia 9
CL - Cile 9
NP - Nepal 9
TN - Tunisia 9
IL - Israele 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
KE - Kenya 7
KG - Kirghizistan 7
PE - Perù 7
UY - Uruguay 7
GE - Georgia 6
JO - Giordania 6
MY - Malesia 6
RO - Romania 6
SN - Senegal 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
GR - Grecia 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
JM - Giamaica 3
KR - Corea 3
KW - Kuwait 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
HU - Ungheria 2
LU - Lussemburgo 2
NI - Nicaragua 2
NO - Norvegia 2
PH - Filippine 2
QA - Qatar 2
SR - Suriname 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
Totale 23.893
Salva come PNG Salva come JPEG
Città #
Dallas 4.950
Moscow 1.147
Jacksonville 1.079
Dublin 888
Singapore 849
Chandler 745
Ashburn 568
Dong Ket 507
Nyköping 482
Beijing 399
Hong Kong 380
San Jose 204
Princeton 178
Cambridge 170
Los Angeles 170
Medford 167
The Dalles 164
Dearborn 149
Lauterbourg 145
Des Moines 133
Boardman 113
Ann Arbor 86
Buffalo 78
New York 71
São Paulo 70
Wilmington 60
Ho Chi Minh City 59
Tianjin 54
Lancaster 49
Guangzhou 46
Belo Horizonte 41
Hanoi 40
Nanjing 40
Jinan 39
Messina 39
Woodbridge 39
San Mateo 38
Milan 37
Munich 37
Vienna 35
Brooklyn 33
Orem 33
Shenyang 32
Redondo Beach 29
Warsaw 27
Brno 26
Rio de Janeiro 26
Houston 25
Brasília 23
Haikou 22
Tokyo 22
Hebei 21
Montreal 21
Stockholm 21
Brussels 19
Chennai 19
Ningbo 19
Chicago 18
Council Bluffs 18
Pune 18
Shanghai 18
Tashkent 18
Denver 17
Frankfurt am Main 17
London 17
Zhengzhou 17
Amsterdam 16
Campinas 16
Phoenix 16
San Francisco 16
Santa Clara 16
Abidjan 15
Nuremberg 15
Shenzhen 15
Johannesburg 14
Norwalk 14
Porto Alegre 14
Baghdad 13
Helsinki 13
Mumbai 13
Ottawa 13
Quito 13
Turku 13
Augusta 12
Boston 12
Changsha 12
Guayaquil 12
Manchester 12
Poplar 12
Taiyuan 12
Atlanta 11
Hangzhou 11
Seattle 11
Ardabil 10
Casablanca 10
Catania 10
Duque de Caxias 10
Fuzhou 10
Istanbul 10
Querétaro 10
Totale 15.553
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.608
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 297
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 287
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 278
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 278
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 270
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 267
1-Adamantanamine derivatives as potential anti-HIV agents 249
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 235
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 198
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 190
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 186
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 184
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 181
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 178
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 177
Anti-HIV agents: design and discovery of new potent RT inhibitors 169
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 166
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 162
Antiretroviral strategy using multi-target agents 162
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 159
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 158
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 158
Graphene Quantum Dots Based Systems As HIV Inhibitors 158
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 151
Annelated 1,5-benzothiazepines 150
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 149
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 149
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 149
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 147
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 147
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 146
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 146
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 144
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 140
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 140
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 139
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 138
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 138
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 137
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 136
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 136
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 136
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 135
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 135
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 135
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 134
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 133
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 133
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 132
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 131
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 130
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 130
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 130
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 128
Synthesis and structural features of new cyclofunctionalized benzimidazoles 126
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 126
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 125
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 125
A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus 125
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 122
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 120
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 120
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 117
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 116
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 114
Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles 113
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 112
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 111
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 111
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 110
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 109
Sintesi e valutazione biologica di (ti)azepinobenzimidazoli come potenziali agenti anti-FMDV 109
ANTI-HIV AGENTS .1. SYNTHESIS AND INVITRO ANTI-HIV EVALUATION OF NOVEL 1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLES 108
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 108
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 107
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 107
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 107
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 103
Rational design, synthesis and SAR of 1,3-dihydro-benzimidazolone analogues as new anti-HIV agents 103
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 102
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 102
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 102
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 99
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 99
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 99
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 98
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 98
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 97
Anti-HIV agents: design and discovery of new potent RT inhibitors 96
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 96
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 95
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 95
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 95
Sintesi ed attività anti-HIV di derivati 4-tiazolidinonici. 93
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent HIV-1 NNRTIs by molecular modeling studies 93
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 93
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 92
TBZ-analoghi inibitori non nucleosidici della HIV-RT 92
Synthesis and stereochemistry of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3-(2H)-ones 92
Totale 18.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021787 0 0 0 0 0 0 0 0 0 142 109 536
2021/20221.057 14 229 26 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/20252.858 54 35 73 212 114 100 31 666 760 116 230 467
2025/202612.527 317 1.805 3.657 699 661 2.055 1.035 1.037 1.020 241 0 0
Totale 24.044